Related Experiment Video

Updated: Mar 31, 2026

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
11:32

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Published on: March 27, 2020

7.5K

Emerging role of N-myc downstream-regulated gene 2 (NDRG2) in cancer

Wei Hu1, Chongxi Fan2, Peng Jiang3

  • 1Department of Biomedical Engineering, The Fourth Military Medical University, Xi'an, China.

Oncotarget
|October 28, 2015
PubMed

Insights

N-myc downstream-regulated gene 2 (NDRG2) functions as a tumor suppressor and is linked to cancer progression. Understanding NDRG2

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • N-myc downstream-regulated gene 2 (NDRG2) is recognized for its role as a tumor suppressor.
  • NDRG2 is implicated in the incidence, progression, and metastasis of various cancers.
  • Its expression is influenced by diverse conditions and potential therapeutic agents.

Purpose of the Study:

  • To review the expression, clinical, and pathological significance of NDRG2 in cancer.
  • To summarize the pathological processes and molecular pathways modulated by NDRG2.
  • To explore mechanisms for enhancing NDRG2 expression and future research directions.

Main Methods:

  • Literature review of existing studies on NDRG2 in cancer.
  • Analysis of NDRG2's role in tumor-associated gene regulation.
  • Summary of molecular pathways and regulatory mechanisms.

Main Results:

  • NDRG2 expression and its clinical relevance in cancer are detailed.
  • Pathological processes and molecular pathways regulated by NDRG2 are elucidated.
  • Mechanisms to increase NDRG2 expression and its therapeutic potential are discussed.

Conclusions:

  • NDRG2 holds significant clinical and pathological importance in cancer.
  • Further research into NDRG2 mechanisms can enhance its therapeutic targeting.
  • Understanding NDRG2 can guide experimental design for cancer treatment.
Keywords:
N-myc downstream-regulated gene 2cancermolecular pathwayspathological processes

More Related Videos

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

909
Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene08:18

Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene

Published on: December 31, 2014

29.0K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
6.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
8.0K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K